NURS6630 Final Exam 1. Questions and Answers
(Latest) Graded A.
Question 1
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera
B. Concerta
C. Daytrana
D. Adderall
Question 2
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg.
B. The child will be prescribed a 10-mg tablet.
C. The child’s dose will increase by 2.5 mg every other week.
D. The child will take 10–40 mg, daily.
Question 3
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.” Based
on self-report from the patient, his parents, and his teacher; attention deficit hyperactivity
disorder (ADHD) is suspected. What medication is the PMNHP most likely to prescribe?
A. Methylphenidate (Ritalin, Concerta)
B. Clonidine (Catapres)
C. Bupropion (Wellbutrin)
D. Desipramine (Norpramin)
Question 4
A 9-year-old female patient presents with symptoms of both attention deficit hyperactivity
disorder (ADHD) and oppositional defiant disorder. In evaluating her symptoms, the PMHNP
determines that which of the following medications may be beneficial in augmenting stimulant
medication?
A. Bupropion (Wellbutrin)
B. Methylphenidate (Ritalin, Concerta)
C. Guanfacine ER (Intuniv)
, D. Atomoxetine (Strattera)
Question 5
Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder (ADHD)
medication for their son. Which medication would the PMHNP start?
A. Methylphenidate
B. Amphetamine salts
C. Atomoxetine
D. All of the above could potentially treat their son’s symptoms.
Question 6
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch.
B. The patient will have one or two doses a day.
C. The patient will take a pill every 17 hours.
D. The dosing should be done in the morning and at night.
Question 7
An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed
topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is
effective in treating which condition(s) in this patient?
A. Migraines
B. Bipolar disorder and depression
C. Pregnancy-induced depression
D. Upper back pain
Question 8
A 26-year-old female patient with nicotine dependence and a history of anxiety presents with
symptoms of attention deficit hyperactivity disorder (ADHD). Based on the assessment, what
does the PMHNP consider?
A. ADHD is often not the focus of treatment in adults with comorbid conditions.
B. ADHD should always be treated first when comorbid conditions exist.
C. Nicotine has no reported impact on ADHD symptoms.
D. Symptoms are often easy to treat with stimulants, given the lack of comorbidity
with other conditions.
Question 9
, The PMHNP is evaluating a 30-year-old female patient who states that she notices pain and a
drastic change in mood before the start of her menstrual cycle. The patient states that she has
tried diet and lifestyle changes but nothing has worked. What will the PMHNP most likely do?
A. Prescribe Estrin FE 24 birth control
B. Prescribe ibuprofen (Motrin), 800 mg every 8 hours as needed for pain
C. Prescribe desvenlafaxine (Pristiq), 50 mg daily
D. Prescribe risperidone (Risperdal), 2 mg TID
Question 10
A 43-year-old male patient is seeking clarification about treating attention deficit hyperactivity
disorder (ADHD) in adults and how it differs from treating children, since his son is on
medication to treat ADHD. The PMHNP conveys a major difference is which of the following?
A. Stimulant prescription is more common in adults.
B. Comorbid conditions are more common in children, impacting the use of stimulants in
children.
C. Atomoxetine (Strattera) use is not advised in children.
D. Comorbidities are more common in adults, impacting the prescription of additional
agents.
Question 11
The PMHNP is assessing a 49-year-old male with a history of depression, post-traumatic stress
disorder (PTSD), alcoholism with malnutrition, diabetes mellitus type 2, and hypertension. His
physical assessment is unremarkable with the exception of peripheral edema bilaterally to his
lower extremities and a chief complaint of pain with numbness and tingling to each leg 5/10. The
PMHNP starts this patient on a low dose of doxepin (Sinequan). What is the next action that
must be taken by the PMHNP?
A. Orders liver function tests.
B. B. Educate the patient on avoiding grapefruits when taking this medication.
C. C. Encourage this patient to keep fluids to 1500 ml/day until the swelling subsides.
D. D. Order a BUN/Creatinine test.
Question 12
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?
A. Venlafaxine (Effexor)
B. Armodafinil (Nuvigil)
C. Bupropion (Wellbutrin)
D. All of the above
Question 13
(Latest) Graded A.
Question 1
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera
B. Concerta
C. Daytrana
D. Adderall
Question 2
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg.
B. The child will be prescribed a 10-mg tablet.
C. The child’s dose will increase by 2.5 mg every other week.
D. The child will take 10–40 mg, daily.
Question 3
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.” Based
on self-report from the patient, his parents, and his teacher; attention deficit hyperactivity
disorder (ADHD) is suspected. What medication is the PMNHP most likely to prescribe?
A. Methylphenidate (Ritalin, Concerta)
B. Clonidine (Catapres)
C. Bupropion (Wellbutrin)
D. Desipramine (Norpramin)
Question 4
A 9-year-old female patient presents with symptoms of both attention deficit hyperactivity
disorder (ADHD) and oppositional defiant disorder. In evaluating her symptoms, the PMHNP
determines that which of the following medications may be beneficial in augmenting stimulant
medication?
A. Bupropion (Wellbutrin)
B. Methylphenidate (Ritalin, Concerta)
C. Guanfacine ER (Intuniv)
, D. Atomoxetine (Strattera)
Question 5
Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder (ADHD)
medication for their son. Which medication would the PMHNP start?
A. Methylphenidate
B. Amphetamine salts
C. Atomoxetine
D. All of the above could potentially treat their son’s symptoms.
Question 6
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch.
B. The patient will have one or two doses a day.
C. The patient will take a pill every 17 hours.
D. The dosing should be done in the morning and at night.
Question 7
An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed
topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is
effective in treating which condition(s) in this patient?
A. Migraines
B. Bipolar disorder and depression
C. Pregnancy-induced depression
D. Upper back pain
Question 8
A 26-year-old female patient with nicotine dependence and a history of anxiety presents with
symptoms of attention deficit hyperactivity disorder (ADHD). Based on the assessment, what
does the PMHNP consider?
A. ADHD is often not the focus of treatment in adults with comorbid conditions.
B. ADHD should always be treated first when comorbid conditions exist.
C. Nicotine has no reported impact on ADHD symptoms.
D. Symptoms are often easy to treat with stimulants, given the lack of comorbidity
with other conditions.
Question 9
, The PMHNP is evaluating a 30-year-old female patient who states that she notices pain and a
drastic change in mood before the start of her menstrual cycle. The patient states that she has
tried diet and lifestyle changes but nothing has worked. What will the PMHNP most likely do?
A. Prescribe Estrin FE 24 birth control
B. Prescribe ibuprofen (Motrin), 800 mg every 8 hours as needed for pain
C. Prescribe desvenlafaxine (Pristiq), 50 mg daily
D. Prescribe risperidone (Risperdal), 2 mg TID
Question 10
A 43-year-old male patient is seeking clarification about treating attention deficit hyperactivity
disorder (ADHD) in adults and how it differs from treating children, since his son is on
medication to treat ADHD. The PMHNP conveys a major difference is which of the following?
A. Stimulant prescription is more common in adults.
B. Comorbid conditions are more common in children, impacting the use of stimulants in
children.
C. Atomoxetine (Strattera) use is not advised in children.
D. Comorbidities are more common in adults, impacting the prescription of additional
agents.
Question 11
The PMHNP is assessing a 49-year-old male with a history of depression, post-traumatic stress
disorder (PTSD), alcoholism with malnutrition, diabetes mellitus type 2, and hypertension. His
physical assessment is unremarkable with the exception of peripheral edema bilaterally to his
lower extremities and a chief complaint of pain with numbness and tingling to each leg 5/10. The
PMHNP starts this patient on a low dose of doxepin (Sinequan). What is the next action that
must be taken by the PMHNP?
A. Orders liver function tests.
B. B. Educate the patient on avoiding grapefruits when taking this medication.
C. C. Encourage this patient to keep fluids to 1500 ml/day until the swelling subsides.
D. D. Order a BUN/Creatinine test.
Question 12
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?
A. Venlafaxine (Effexor)
B. Armodafinil (Nuvigil)
C. Bupropion (Wellbutrin)
D. All of the above
Question 13
